The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The use of docetaxel as a radiosensitizer in patients with head and neck cancer unsuitable for cisplatin based chemoradiation: Landmark 3-year survival analysis of a randomized phase III trial (DHANUSH).
 
Sneha Dhar
No Relationships to Disclose
 
Vanita Noronha
Research Funding - AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Roche India (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Minit Shah
No Relationships to Disclose
 
Nandini Menon
No Relationships to Disclose
 
Vijay Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Sarbani Laskar
No Relationships to Disclose
 
Ashwini Budrukkar
No Relationships to Disclose
 
Monali Swain
No Relationships to Disclose
 
Shwetabh Sinha
No Relationships to Disclose
 
Anuj Kumar S
No Relationships to Disclose
 
Nivedita Chakrabarty
No Relationships to Disclose
 
Amit Janu
No Relationships to Disclose
 
Kamesh Maske
No Relationships to Disclose
 
Ankush Shetake
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); Aurigene Oncology Limited (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); Johnson and Johnson (Inst); NATCO Pharma (Inst); Roche (Inst)